ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,730,000 | -3.8% | 119,708 | 0.0% | 0.81% | +17.6% |
| Q2 2019 | $4,918,000 | -46.7% | 119,708 | -39.6% | 0.69% | -49.6% |
| Q1 2019 | $9,233,000 | -49.6% | 198,261 | -52.8% | 1.37% | -47.0% |
| Q4 2018 | $18,304,000 | -50.8% | 420,293 | -35.3% | 2.58% | -12.7% |
| Q3 2018 | $37,200,000 | -30.5% | 650,000 | -41.1% | 2.95% | -45.2% |
| Q2 2018 | $53,563,000 | -11.8% | 1,103,937 | -29.0% | 5.39% | -29.3% |
| Q1 2018 | $60,759,000 | -7.9% | 1,553,937 | 0.0% | 7.62% | -17.6% |
| Q4 2017 | $65,949,000 | +13.7% | 1,553,937 | 0.0% | 9.24% | +22.5% |
| Q3 2017 | $57,993,000 | +22.8% | 1,553,937 | 0.0% | 7.55% | +33.6% |
| Q2 2017 | $47,224,000 | +14.8% | 1,553,937 | 0.0% | 5.65% | +29.0% |
| Q1 2017 | $41,133,000 | +30.0% | 1,553,937 | +25.3% | 4.38% | +45.3% |
| Q4 2016 | $31,649,000 | -3.2% | 1,240,173 | +37.2% | 3.01% | +3.8% |
| Q3 2016 | $32,710,000 | +40.4% | 903,833 | +31.8% | 2.90% | +18.7% |
| Q2 2016 | $23,306,000 | +31.2% | 685,863 | +1.9% | 2.45% | +25.7% |
| Q1 2016 | $17,762,000 | – | 673,063 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |